As employers and insurers continue expanding benefits to address rising obesity-related healthcare costs, more patients gain access to GLP-1 therapies that provide clinically proven reductions in weight and cardiometabolic risk
thereby prolonging the ability to live independently
Over All health equality
4,500+ seniors enrolled across 34 states 4.8 average rating from seniors Our devices have been featured in The Wall Street Journal CNN healthline AARP * All results refer to participation in MDWatchs Program, which combines personalized coaching, nutrition and lifestyle support, exercise, and, when clinically appropriate, compounded GLP-1 medication dispensed by licensed pharmacies pursuant to a prescription
Some clients book weekly or biweekly shots for ongoing support, while others schedule as needed
-- orders placed in the last 24 hours Description IMPORTANT NOTICE All articles and product information provided on this website are for informational and educational purposes only